New Inactivated Polio Vaccines Recommended For Approval
This article was originally published in PharmAsia News
The Second Committee on Drugs of Japan's Ministry of Health, Labor, and Welfare announced July 20 it would be advisable to approve the production and sale of the quadruple inactivated polio-DPT vaccine developed by two domestic companies.
You may also be interested in...
Inovio forges ahead into Phase I trials with DNA-based vaccine candidate, but can it prove skeptics wrong?
With hospitals throughout the EU short of urgently needed COVID-19 medical supplies, including respiratory equipment, there are ways for companies to sell and deliver their products quickly.
Entries for the Scrip Awards are now open. Now in their 16th year, the Awards seek to reward the outstanding achievements of the pharmaceutical, biotech and allied industries in improving human health and will take place in London on 2 December.